6 completed, 1 unknown. 3 Not applicable, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow Filip Krag Knop: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of Amylin in Bone Metabolism Pramlintide, Placebo (saline) infusion - Bone Diseases, Metabolic, Type 1 Diabetes | Not applicable | Unknown | Filip Krag Knop | 20 | 2024-02-12 | 2024-02-21 |
| Treatment of Post-bariatric Hypoglycaemia Dasiglucagon, HyoPen, Placebo - Hyperinsulinemic Hypoglycemia, Postprandial Hypoglycemia | Phase 2 | Completed | Filip Krag Knop | 24 | 2021-08-20 | 2023-02-02 |
| Treatment of Bile Acid Malabsorption With Liraglutide Liraglutide 6 MG/ML, Colesevelam - Bile Acid Malabsorption | Phase 4 | Completed | Filip Krag Knop | 52 | 2019-03-07 | 2022-06-03 |
| Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases Exenatide, Placebos - Diabetes Mellitus, Type 1 | Phase 2 | Completed | Filip Krag Knop | 108 | 2016-12-01 | 2019-07-10 |
| The Endocrine Secretome After Gastric Bypass Surgery Enteroscopy with biopsy sampling and mixed meal test - Obesity, Morbid, Type2 Diabetes | Not applicable | Completed | Filip Krag Knop | 28 | 2014-12-12 | 2017-03-28 |
| The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones EndoBarrier Gastrointestinal Liner - Type 2 Diabetes, Obesity | Completed | Filip Krag Knop | 25 | 2013-02-01 | 2017-08-10 | |
| The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion Acetaminophen, Metformin, Colesevelam - To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion | Not applicable | Completed | Filip Krag Knop | 10 | 2012-07-01 | 2015-07-14 |
Diabetes Mellitus, Type 1 (2) · Bone Diseases, Metabolic (1) · Congenital Hyperinsulinism (1) · Diabetes Mellitus, Type 2 (1) · Hypoglycemia (1) · Insulin Resistance (1) · Obesity (1) · Obesity, Morbid (1)
Colesevelam Hydrochloride (2) · Sodium Chloride (2) · Acetaminophen (1) · Exenatide (1) · Liraglutide (1) · Metformin (1) · Sincalide (1) · dasiglucagon (1) · desulfated sincalide (1) · pramlintide (1)
Denmark (6)
Ulrich Rohde, MD (2) · Filip K Knop, MD PhD (1) · Filip K Knop, MD, Ph.D. (1) · Filip K Knop, MD, PhD (1) · Filip K. Knop, Professor, MD, PhD (1) · Filip Knop, MD, prof. (1)
PMID 27003305, PMID 31276156, PMID 32135138, PMID 33150746, PMID 40004948